VistaGen Therapeutics Financial Overview
VistaGen Therapeutics's market cap is currently $150.08M. The company's EPS TTM is $-0.54; its P/E ratio is ―; VistaGen Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
